Report from the 24th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Richmond, British Columbia, 28–29, October 2022-Reference-Cited by-同舟云学术

Report from the 24th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Richmond, British Columbia, 28–29, October 2022

Published:2023-08-29 Issue:9 Volume:30 Page:7964-7983
ISSN:1718-7729
Container-title:Current Oncology
language:en
Short-container-title:Current Oncology

Author:

Gill Sharlene¹^ORCID,Ahmed Shahid²^ORCID,Anderson Brady³,Berry Scott⁴,Lim Howard¹,Phang Terry⁵^ORCID,Sharma Ankur⁶,Solar Vasconcelos Joao Paulo¹,Gill Karamjit¹,Iqbal Mussawar⁷,Tankel Keith⁸,Chan Theresa⁹,Recsky Magdalena¹⁰,Nuk Jennifer¹¹,Paul James¹²,Mahmood Shazia⁸

Affiliation:

1. British Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada

2. Saskatchewan Cancer Agency, Saskatoon, SK S4W 0G3, Canada

3. Western Manitoba Cancer Center, Brandon, MB R7A 5M8, Canada

4. Department of Oncology, Queen’s University, Kingston, ON K7L 3N6, Canada

5. Department of Surgery, University of British Columbia, Vancouver, BC V6T 1Z4, Canada

6. Central Alberta Cancer Centre, School of Medicine, University of Calgary Cumming, Red Deer, AB T4N 6R2, Canada

7. Allan Blair Cancer Centre, Regina, SK S4T 7T1, Canada

8. Cross Cancer Institute, Edmonton, AB T6G 1Z2, Canada

9. British Columbia Cancer Agency, Surrey, BC V3V 1Z2, Canada

10. Kelowna General Hospital, Kelowna, BC V1Y 1T2, Canada

11. British Columbia Cancer Hereditary Cancer Program, Victoria, BC V8R 6V5, Canada

12. CancerCare Manitoba, University of Manitoba, Winnipeg, MB R3E 0V9, Canada

Abstract

The 24th annual Western Canadian Gastrointestinal Cancer Consensus Conference (WCGCCC) was held in Richmond, British Columbia, on 28–29 October 2022. The WCGCCC is an interactive multidisciplinary conference attended by healthcare professionals from across Western Canada (British Columbia, Alberta, Saskatchewan, and Manitoba) who are involved in the care of patients with gastrointestinal cancer. Surgical, medical, and radiation oncologists; pathologists; radiologists; and allied health care professionals such as dieticians, nurses and a genetic counsellor participated in presentation and discussion sessions for the purpose of developing the recommendations presented here. This consensus statement addresses current issues in the management of colorectal cancer.

Funder

Pfizer

Eisai

Amgen

Astellas Pharma

Incyte Corporation

Merck & Co.

Taiho Pharmaceutical,

BeiGene

Bristol Myers Squibb

AstraZeneca

Publisher